Invitae Corp and ArcherDX Inc To Create Global Leader In Comprehensive Cancer Genetics And Precision Oncology Call Transcript

Jun 22, 2020 / 12:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Invitae and ArcherDX Investor Call. (Operator Instructions)

I would now like to hand the conference over to your speaker for today, Laura D'Angelo, Head of Investor Relations. Please go ahead, ma'am.

Laura D'Angelo - Invitae Corporation - Head of IR

Thank you, operator, and good morning, everyone. Thank you for joining us for our call today. Joining us today from Invitae are Sean George, Co-Founder and CEO; Shelly Guyer, CFO; Lee Bendekgey, COO; Robert Nussbaum, Chief Medical Officer; Katherine Stueland, Chief Commercial Officer; and we're pleased to welcome Jason Myers, CEO and Co-Founder of ArcherDx.

As you listen to today's conference call, we encourage you to have our press release available currently posted to the Invitae Investor Relations website, which includes details and commentary on the transaction. The slides we'll be using today are also available under the News and Events section of the Invitae Investor Relations website.

Before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot